These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 4238357)

  • 1. [Drugs that act through enzymes].
    Cuparencu B
    Fiziol Norm Patol; 1969; 15(1):11-9. PubMed ID: 4238357
    [No Abstract]   [Full Text] [Related]  

  • 2. [Pharmacology of the adrenergic system. II. Interference of drugs with catecholamine storage in and release from the adrenergic system].
    Ariëns EJ
    Ned Tijdschr Geneeskd; 1970 Aug; 114(33):1369-76. PubMed ID: 4393655
    [No Abstract]   [Full Text] [Related]  

  • 3. [Pharmacology of ocular hemodynamics (review of the literature)].
    Iasnetsov VS; Bozhefatov AS; Iasnetsova NM
    Farmakol Toksikol; 1981; 44(2):233-8. PubMed ID: 7023970
    [No Abstract]   [Full Text] [Related]  

  • 4. Changes in cochlear blood flow in guinea pigs in response to autonomic drugs and vasodilating agents.
    Suga F; Snow JB
    Surg Forum; 1968; 19():479-80. PubMed ID: 5718713
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effect of drugs on regulatory enzymes in metabolic pathways].
    Gumińska M
    Folia Med Cracov; 1980; 22(3-4):241-61. PubMed ID: 7026383
    [No Abstract]   [Full Text] [Related]  

  • 6. Ophthalmic drugs and anesthesia interactions.
    Kopecky J
    CRNA; 1992 Feb; 3(1):16-21. PubMed ID: 1477681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of foreign compounds on elasmobranchs and the effect of elasmobranchs on foreign compounds.
    Adamson RH; Guarino AM
    Comp Biochem Physiol A Comp Physiol; 1972 May; 42(1):171-82. PubMed ID: 4402706
    [No Abstract]   [Full Text] [Related]  

  • 8. Some facts on drug--enzyme interactions and their relevance in discovery of new drugs.
    Ahmad SI
    J Pak Med Assoc; 1975 Jun; 25(6):136-9. PubMed ID: 814310
    [No Abstract]   [Full Text] [Related]  

  • 9. The effect of catecholamines on the adenyl cyclase of frog and tadpole hemolysates.
    Rosen OM; Rosen SM
    Biochem Biophys Res Commun; 1968 Apr; 31(1):82-91. PubMed ID: 4296878
    [No Abstract]   [Full Text] [Related]  

  • 10. [Pharmacology of the pulmonary circulation].
    Zocche GP
    Minerva Anestesiol; 1967 Jan; 33(1):74-7. PubMed ID: 5596016
    [No Abstract]   [Full Text] [Related]  

  • 11. [Behavior of blood catecholamines under the action of sympathomimetic and sympatholytic drugs].
    Di Biase G; Labriola E
    Arch Patol Clin Med; 1965 Dec; 42(2):114-25. PubMed ID: 5860702
    [No Abstract]   [Full Text] [Related]  

  • 12. Designing of novel carbonic anhydrase inhibitors and activators.
    Supuran CT; Vullo D; Manole G; Casini A; Scozzafava A
    Curr Med Chem Cardiovasc Hematol Agents; 2004 Jan; 2(1):49-68. PubMed ID: 15328829
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of adrenergic agents on carbohydrate metabolism of rat liver: activities of adenyl cyclase and glycogen phosphorylase.
    Newton NE; Hornbrook KR
    J Pharmacol Exp Ther; 1972 Jun; 181(3):479-88. PubMed ID: 5033014
    [No Abstract]   [Full Text] [Related]  

  • 14. [Adrenergic mechanisms as basis of pharmacological agent action. I].
    Fermum R
    Z Arztl Fortbild (Jena); 1968 Jan; 62(2):109-15. PubMed ID: 4302478
    [No Abstract]   [Full Text] [Related]  

  • 15. Carbonic anhydrase inhibitors: 2-substituted-1,3,4-thiadiazole-5-sulfamides act as powerful and selective inhibitors of the mitochondrial isozymes VA and VB over the cytosolic and membrane-associated carbonic anhydrases I, II and IV.
    Smaine FZ; Pacchiano F; Rami M; Barragan-Montero V; Vullo D; Scozzafava A; Winum JY; Supuran CT
    Bioorg Med Chem Lett; 2008 Dec; 18(24):6332-5. PubMed ID: 18990571
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carbonic anhydrase inhibitors: the beta-carbonic anhydrase from Helicobacter pylori is a new target for sulfonamide and sulfamate inhibitors.
    Nishimori I; Minakuchi T; Kohsaki T; Onishi S; Takeuchi H; Vullo D; Scozzafava A; Supuran CT
    Bioorg Med Chem Lett; 2007 Jul; 17(13):3585-94. PubMed ID: 17482815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of carbonic anhydrase by nitric oxide.
    Puscas I; Coltau M
    Arzneimittelforschung; 1995 Aug; 45(8):846-8. PubMed ID: 7575744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adrenotropic drugs in lipid mobilization.
    Wenke M
    Horm Metab Res; 1970; 2():Suppl 2:55-62. PubMed ID: 4403190
    [No Abstract]   [Full Text] [Related]  

  • 19. [Current trends in the therapeutic use of enzyme inhibitors in clinical practice].
    Veremeenko KN
    Vrach Delo; 1969 Nov; 11():11-9. PubMed ID: 4988514
    [No Abstract]   [Full Text] [Related]  

  • 20. Two-prong inhibitors for human carbonic anhydrase II.
    Roy BC; Banerjee AL; Swanson M; Jia XG; Haldar MK; Mallik S; Srivastava DK
    J Am Chem Soc; 2004 Oct; 126(41):13206-7. PubMed ID: 15479058
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.